• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Economic Data

Day Ahead: Awash in Earnings

Futures point higher; blockbuster drug deal boosts European markets.
By PAUL CURCIO Apr 22, 2014 | 09:00 AM EDT
Stocks quotes in this article: MCD, UTX, TRV, NFLX, GSK, NVS, LLY, AGN

U.S. stock futures were pointing higher Tuesday as earnings reports poured in and investors awaited more data on the health of the economy.

Three Dow components, McDonald's (MCD), United Technologies (UTX) and Travelers (TRV), reported results this morning. McDonald's missed on the top and bottom lines, United Tech beat earnings forecasts by a nickel per share, and Travelers arrived a penny ahead of EPS estimates.

Last night Netflix (NFLX) beat Wall Street expectations, and shares were higher in premarket trading.

On the economic docket, at 9 a.m. ET, the Federal Housing Finance Agency's Housing Price Index for February is expected to pull back to 0.03% from 0.5% in January. Analysts see existing-home sales receding to 4.56 million in March from 4.6 million the previous month. That report comes out at 10 a.m. At the same time, the Richmond Federal Reserve is set to release its manufacturing index.

Overseas, Asian markets were lower and European markets were boosted by a blockbuster deal among big pharma names. The U.K.'s GlaxoSmithKline (GSK), Switzerland's Novartis (NVS) and Eli Lilly (LLY) made a multi-billion-dollar swap that refocused their businesses. As a result, Novartis will concentrate on cancer drugs and Glaxo on vaccines, and Lilly will take a greater hand in veterinary medicine.

Meanwhile, shares of Allergan (AGN) soared in the premarket on news that Canada's Valeant Pharmaceuticals International (VRX) made a bid for the Botox maker. Hedge fund Pershing Square, managed by Bill Ackman, has a 9.7% stake in Allergan and supports the deal.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Follow Paul Curcio on Twitter @CurcioStreet

TAGS: Investing | U.S. Equity | Economic Data

More from Economic Data

China's Economy, Retail Sales, Helicopter Money, Walmart's Autonomous Vehicles

Stephen Guilfoyle
Apr 16, 2021 8:09 AM EDT

The 'organic' economy has to take over at some point, and at that point, at least in theory, demand for credit should accelerate.

S&P 500 Turns Near-Term Neutral

Guy Ortmann
Apr 15, 2021 10:03 AM EDT

Sentiment data remain cautionary.

How 'Inflated' PCE Figures Might Affect Fed Rate Hikes

Tom Graff
Apr 14, 2021 10:30 AM EDT

Prices are rising, but the data is messy, especially right now. Here is how I'm thinking about it, and when the Fed might hike rates as a result.

Is the Uptick in Inflation Just a Blip?

Bret Jensen
Apr 14, 2021 9:00 AM EDT

If investors start to factor in higher inflation, we could be looking at a big increase in volatility in the months ahead.

Bank Earnings, Late Day Market Surges, Vaccine Update, Trading Coinbase

Stephen Guilfoyle
Apr 14, 2021 7:33 AM EDT

Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:05 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How recency bias and the Pareto Principle impact y...
  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login